10. Meta‐analysis: Part 2: assessing the quality of published meta‐analyses
暂无分享,去创建一个
[1] D Elbourne,et al. The effects of routine oxytocic administration in the management of the third stage of labour: an overview of the evidence from controlled trials , 1988, British journal of obstetrics and gynaecology.
[2] G. Oster,et al. RATES OF VENOUS THROMBOSIS AFTER GENERAL SURGERY: COMBINED RESULTS OF RANDOMISED CLINICAL TRIALS , 1986, The Lancet.
[3] P. Gøtzsche,et al. PATIENTS' PREFERENCE IN INDOMETHACIN TRIALS: AN OVERVIEW , 1989, The Lancet.
[4] D. Henry,et al. Meta-analysis. Part 1: An assessment of its aims, validity and reliability. , 1992, The Medical journal of Australia.
[5] T C Chalmers,et al. Should mild hypertension be treated? An attempted meta-analysis of the clinical trials. , 1985, The Mount Sinai journal of medicine, New York.
[6] N. Laird,et al. Meta-analysis in clinical trials. , 1986, Controlled clinical trials.
[7] W. Schaffner,et al. Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons. , 1988, Annals of internal medicine.
[8] L Mutch,et al. The Oxford Database of Perinatal Trials: developing a register of published reports of controlled trials. , 1986, Controlled clinical trials.
[9] A. Blower,et al. Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration. , 1987, Gut.
[10] R. Collins,et al. Blood pressure, stroke, and coronary heart disease Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context , 1990, The Lancet.
[11] R. Collins,et al. Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. , 1985, European heart journal.
[12] David B. Pillemer,et al. Summing Up: The Science of Reviewing Research , 1984 .
[13] M. Langman,et al. NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND BLEEDING PEPTIC ULCER , 1986, The Lancet.
[14] D. Henry,et al. The benefits of reducing cholesterol levels: the need to distinguish primary from secondary prevention: 1. A meta‐analysis of cholesterol‐lowering trials , 1991, The Medical journal of Australia.
[15] D. Fromm. Endoscopic coagulation for gastrointestinal bleeding. , 1987, The New England journal of medicine.
[16] R. Simes. Publication bias: the case for an international registry of clinical trials. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] D Fleischer,et al. Endoscopic therapy of upper gastrointestinal bleeding in humans. , 1986, Gastroenterology.
[18] Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico.,et al. EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION , 1986, The Lancet.
[19] T C Chalmers,et al. Meta-analysis of clinical trials as a scientific discipline. I: Control of bias and comparison with large co-operative trials. , 1987, Statistics in medicine.
[20] L. Hedges. Estimation of effect size from a series of independent experiments. , 1982 .
[21] R. Rosenthal. The file drawer problem and tolerance for null results , 1979 .
[22] R. Peto,et al. Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.
[23] J. Berlin,et al. Meta‐analysis of randomized controlled trials as a method of estimating rare complications of non‐steroidal anti‐inflammatory drug therapy , 1988, Alimentary pharmacology & therapeutics.
[24] R. Simes,et al. Confronting publication bias: a cohort design for meta-analysis. , 1987, Statistics in medicine.
[25] A. Banerjee,et al. Non-Steroidal Anti-Inflammatory Drugs and Gastrointestinal Adverse Effects , 1983, Journal of the Royal College of Physicians of London.
[26] C. Begg,et al. Publication bias : a problem in interpreting medical data , 1988 .
[27] T. Caradoc-Davies,et al. Nonsteroidal anti-inflammatory drugs, arthritis, and gastrointestinal bleeding in elderly in-patients. , 1984, Age and ageing.
[28] T C Chalmers,et al. A comparison of statistical methods for combining event rates from clinical trials. , 1989, Statistics in medicine.
[29] K A L'Abbé,et al. Meta-analysis in clinical research. , 1987, Annals of internal medicine.
[30] A. Dobson,et al. NSAIDs and risk of upper gastrointestinal bleeding , 1991, The Lancet.
[31] G H Guyatt,et al. Guidelines for reading literature reviews. , 1988, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[32] A. Detsky,et al. Parenteral nutrition with branched-chain amino acids in hepatic encephalopathy. A meta-analysis. , 1989, Gastroenterology.
[33] T C Chalmers,et al. A method for assessing the quality of a randomized control trial. , 1981, Controlled clinical trials.
[34] D. Henry,et al. Effects of fibrinolytic inhibitors on mortality from upper gastrointestinal haemorrhage. , 1989, BMJ.
[35] R Peto,et al. Effect of intravenous streptokinase on acute myocardial infarction: pooled results from randomized trials. , 1982, The New England journal of medicine.
[36] R. Peto,et al. Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women. , 1989, The New England journal of medicine.
[37] J. Baron,et al. Effect of intravenous streptokinase on early mortality in patients with suspected acute myocardial infarction. A meta-analysis by anatomic location of infarction . , 1990, Annals of internal medicine.
[38] K. McPherson,et al. Secondary prevention of vascular disease by prolonged antiplatelet treatment , 1988, British medical journal.
[39] P. Easterbrook,et al. Publication bias in clinical research , 1991, The Lancet.